poloxalene has been researched along with phosphatidylcholines in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, RF; Cotias, PM; Mendes, AR; Ramos de Souza, AS; Salles, CA | 1 |
| Draffehn, J; Gross, U; Reichelt, H; Rüdiger, S | 1 |
| Quirion, F; St-Pierre, S | 1 |
| Barrowman, JA; Hall, J; Nutting, D; Tso, P | 1 |
| Hammerschmidt, DE; Vercellotti, GM | 1 |
| Black, DD; Drake, DS; Sabesin, SM; Tso, P | 1 |
| Beeler, DA; Rodgers, JB; Tso, P | 1 |
| Murphy, JC; Sharma, V; Stebe, K; Tung, L | 1 |
| Hincal, AA; Oner, F; Oner, L; Yalin, M | 1 |
| Burgess, DJ; Yoon, JK | 1 |
| Liang, X; Mao, G; Ng, KY | 1 |
| Deng, J; Li, WG; Ning, Q; Yu, DN; Zhou, Y | 1 |
| Basalious, EB; Shamma, RN | 1 |
| Balakrishnan, P; Cho, HJ; Jahn, A; Song, CK | 1 |
14 other study(ies) available for poloxalene and phosphatidylcholines
| Article | Year |
|---|---|
An infallible method for producing ascitic fluid from solid tumours.
Topics: Animals; Ascites; Detergents; Fibrosarcoma; Heparin; Phosphatidylcholines; Poloxalene; Rats; Sarcoma, Yoshida; Surface Properties | 1975 |
Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
Topics: Blood Substitutes; Drug Stability; Emulsions; Fluorocarbons; Liposomes; Phosphatidylcholines; Poloxalene; Viscosity | 1992 |
Reduction of the in vitro hemolytic activity of soybean lecithin liposomes by treatment with a block copolymer.
Topics: Erythrocytes; Ethylene Glycol; Ethylene Glycols; Glycine max; Hemolysis; Humans; In Vitro Techniques; Liposomes; Osmotic Fragility; Phosphatidylcholines; Poloxalene; Propylene Glycol; Propylene Glycols | 1991 |
Further studies on the mechanism of inhibition of intestinal chylomicron transport by Pluronic L-81.
Topics: Animals; Biological Transport; Chylomicrons; Intestinal Mucosa; Lipoproteins, VLDL; Lymph; Male; Oleic Acid; Oleic Acids; Phosphatidylcholines; Poloxalene; Polyethylene Glycols; Rats; Rats, Inbred Strains; Triglycerides | 1989 |
Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.
Topics: Adamantane; Blood Substitutes; Complement Activation; Complement C3; Complement C3a; Drug Combinations; Emulsions; Excipients; Fluorocarbons; Granulocytes; Humans; Hydroxyethyl Starch Derivatives; Male; Middle Aged; Phosphatidylcholines; Poloxalene | 1988 |
Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine.
Topics: Animals; Apolipoproteins; Biological Transport; Cholesterol; Chylomicrons; Eggs; Electrophoresis, Agar Gel; Intestine, Small; Lipid Metabolism; Lipoproteins; Lipoproteins, VLDL; Lymph; Lymphatic System; Male; Particle Size; Phosphatidylcholines; Phospholipids; Poloxalene; Rats; Rats, Inbred Strains; Tissue Distribution; Triglycerides | 1984 |
Relationship of phosphatidylcholine to hydrophobic surfactant on rat intestinal chylomicron secretion.
Topics: Animals; Chylomicrons; Duodenum; Intestinal Absorption; Intestinal Mucosa; Lymph; Male; Phosphatidylcholines; Poloxalene; Rats; Rats, Sprague-Dawley; Triglycerides; Triolein | 1996 |
Poloxamer 188 decreases susceptibility of artificial lipid membranes to electroporation.
Topics: Electric Conductivity; Electroporation; Kinetics; Lipid Bilayers; Models, Chemical; Patch-Clamp Techniques; Phosphatidylcholines; Phospholipids; Poloxalene; Surface-Active Agents; Time Factors | 1996 |
Preparation and properties of a stable intravenous lorazepam emulsion.
Topics: Animals; Anti-Anxiety Agents; Drug Stability; Emulsions; Excipients; Hemolysis; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Lorazepam; Phosphatidylcholines; Poloxalene; Rabbits | 1997 |
Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions.
Topics: Chemical Phenomena; Chemistry, Physical; Cholesterol; Drug Stability; Emulsions; Excipients; Fluorocarbons; Phosphatidylcholines; Poloxalene; Surface Properties; Surface-Active Agents; Temperature | 1996 |
Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation.
Topics: Drug Stability; Egg White; Light; Lipid Bilayers; Microscopy, Atomic Force; Models, Molecular; Phosphatidylcholines; Poloxalene; Scattering, Radiation; Structure-Activity Relationship | 2005 |
Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Capsules; Cardiovascular Agents; Cholesterol; Drug Delivery Systems; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Liposomes; Male; Particle Size; Permeability; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Sprague-Dawley | 2014 |
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
Topics: Administration, Oral; Animals; Biological Availability; Biological Transport; Brain; Calcium Channel Blockers; Intestinal Absorption; Male; Micelles; Nanotubes; Nimodipine; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Wistar; Solubility | 2015 |
Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Ceramides; Chemistry, Pharmaceutical; Delayed-Action Preparations; Docetaxel; Excipients; Male; Mice; Nanoparticles; Neoplasms; Particle Size; Phosphatidylcholines; Poloxalene; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Sphingosine; Taxoids | 2016 |